You are here
Found 46 results
Filters: keyword is Magnetic Resonance [Clear All Filters]
2008
.
2008. Analysis of the thermodynamics of binding of an SH3 domain to proline-rich peptides using a chimeric fusion protein.
377(1):117-135. Abstract
2007
.
2007. The high resolution NMR structure of the third SH3 domain of CD2AP.
39(4):331-336. Abstract
.
2007. The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex.
581(4):687-692. Abstract
.
2007. Structure and localization of an essential transmembrane segment of the proton translocation channel of yeast H+-V-ATPase.
1768(2):218-227. Abstract
.
2007. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
7:22. Abstract
2006
.
2006. Comparative NMR study on the impact of point mutations on protein stability of Pseudomonas mendocina lipase.
15(8):1915-1927. Abstract
.
2006. The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding.
7(2):257-267. Abstract
2005
.
2005. The solution structure of a transient photoreceptor intermediate: Delta25 photoactive yellow protein.
13(7):953-962. Abstract
.
2005. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
579(9):1917-1922. Abstract
2004
.
2004. How thioredoxin can reduce a buried disulphide bond.
J. Mol. Biol.. 339(3):527-537. Abstract
.
2004. Detection and characterization of partially unfolded oligomers of the SH3 domain of alpha-spectrin.
86(4):2403-2413. Abstract
2003
.
2003. Lack of negative charge in the E46Q mutant of photoactive yellow protein prevents partial unfolding of the blue-shifted intermediate.
42(49):14501-14506. Abstract
.
2003. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.
424(6950):783-788. Abstract
.
2003. Rapid formation of non-native contacts during the folding of HPr revealed by real-time photo-CIDNP NMR and stopped-flow fluorescence experiments.
330(2):397-407. Abstract
.
2003. Purification of an oxidation-sensitive enzyme, pI258 arsenate reductase from Staphylococcus aureus.
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.. 790(1-2):217-227. Abstract
.
2003. NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
278(15):13110-13117. Abstract
.
2003. On the molecular basis of the recognition of angiotensin II (AII). NMR structure of AII in solution compared with the X-ray structure of AII bound to the mAb Fab131.
270(5):849-860. Abstract
2002
.
2002. All intermediates of the arsenate reductase mechanism, including an intramolecular dynamic disulfide cascade.
Proc. Natl. Acad. Sci. USA. 99(13):8506-8511. Abstract
.
2002. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
41(24):7670-7676. Abstract
.
2002. Kinetics and active site dynamics of Staphylococcus aureus arsenate reductase.
J. Biol. Inorg. Chem.. 7(1-2):146-156. Abstract
2001
.
2001. A partially folded intermediate species of the beta-sheet protein apo-pseudoazurin is trapped during proline-limited folding.
10(6):1216-1224. Abstract
.
2001. 1H, 13C and 15N backbone resonance assignment of the arsenate reductase from Staphylococcus aureus in its reduced state.
J. Biomol. NMR. 20(1):95-96.
2000
.
2000. Thermodynamic analysis of helix-engineered forms of the activation domain of human procarboxypeptidase A2.
267(19):5891-5899. Abstract
1999
.
1999. Hydrogen-exchange stabilities of RNase T1 and variants with buried and solvent-exposed Ala --> Gly mutations in the helix.
Biochemistry. 38(50):16481-16490. Abstract